Sanchez-Guajardo Vanesa, Borghans José A M, Marquez Maria-Elena, Garcia Sylvie, Freitas Antonio A
Lymphocyte Population Biology Unit, Institute Pasteur, France.
J Immunol. 2005 Feb 1;174(3):1178-87. doi: 10.4049/jimmunol.174.3.1178.
The outcome of an immune response relies on the competitive capacities acquired through differentiation of CD4(+) T cells into Th1 or Th2 effector cells. Because Stat4 and Stat6 proteins are implicated in the Th1 vs Th2 generation and maintenance, respectively, we compare in this study the kinetics of Stat4(-/-) and Stat6(-/-) CD4(+) T cells during competitive bone marrow reconstitution and lymphopenia-driven proliferation. After bone marrow transplantation, both populations reconstitute the peripheral T cell pools equally well. After transfer into lymphopenic hosts, wild-type and Stat6(-/-) CD4(+) T cells show a proliferation advantage, which is early associated with the expression of an active phospho-Stat4 and the down-regulation of Stat6. Despite these differences, Stat4- and Stat6-deficient T cells reach similar steady state numbers. However, when both Stat4(-/-) and Stat6(-/-) CD4(+) T cells are coinjected into the same hosts, the Stat6(-/-) cells become dominant and out-compete Stat4(-/-) cells. These findings suggest that cell activation, through the Stat4 pathway and the down-regulation of Stat6, confers to pro-Th1 T cells a slight proliferation advantage that in a competitive situation has major late repercussions, because it modifies the final homeostatic equilibrium of the populations and favors the establishment of Th1 CD4(+) T cell dominance.
免疫反应的结果取决于CD4(+) T细胞分化为Th1或Th2效应细胞所获得的竞争能力。由于Stat4和Stat6蛋白分别参与Th1与Th2细胞的产生和维持,我们在本研究中比较了Stat4(-/-)和Stat6(-/-) CD4(+) T细胞在竞争性骨髓重建和淋巴细胞减少驱动的增殖过程中的动力学。骨髓移植后,这两种细胞群对外周T细胞库的重建效果相当。转入淋巴细胞减少的宿主后,野生型和Stat6(-/-) CD4(+) T细胞显示出增殖优势,这与活性磷酸化Stat4的表达及Stat6的下调早期相关。尽管存在这些差异,Stat4和Stat6缺陷的T细胞达到相似的稳态数量。然而,当将Stat4(-/-)和Stat6(-/-) CD4(+) T细胞共同注射到同一宿主中时,Stat6(-/-)细胞占主导地位并胜过Stat4(-/-)细胞。这些发现表明,通过Stat4途径的细胞活化和Stat6的下调赋予Th1前体细胞轻微的增殖优势,在竞争情况下这种优势会产生重大的后期影响,因为它改变了细胞群的最终稳态平衡并有利于Th1 CD4(+) T细胞优势地位的确立。